You are here

Abattis Bioceuticals Corp.

Listing Exchange: 
CSE
Status: 
Suspended
Industry: 
Life Sciences
Symbol: 
ATT
CSE Index: 
Currency: 

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds. Abattis develops and is in the process of commercializing natural health products that target ailments and satisfy important market needs. Abattis is conducting ongoing research and development to create plant-based intellectual property and ingredients. Current areas of focus are growth through acquisition and business development and cash flow through commercialization of existing assets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. Abattis follows strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company's website at: www.abattis.com.

You are here

Abattis Bioceuticals Corp. (ATT)

SEDAR Information

Company Info

Address
1200 - 625 Howe Street
Vancouver, BC V6C 2M6
Canada
Phone
604-674-8232
Email
news@abattis.com
Website
http://www.abattis.com
Listing date
Thursday, December 23, 2010
Transfer Agent
Computershare Investor Services Inc.
Auditor
NVS Chartered Accountants

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
352,529,829
Reserved for Issuance: 
0

Bulletins

Advertisement

Publicité

Latest CSE News

Upcoming Events

09-22_Extraordinary_Future_2019_Website

Extraordinary Future 2019

Sunday, September 22, 2019 (All day) to Monday, September 23, 2019 (All day)
09-26_4th_CEO_Summit_2019-Website

4th CEO Summit 2019

Thursday, September 26, 2019 -
9:00am to 1:30pm